CLASS II ONGOING Device recall · Reported 19 Apr 2023 · FDA Enforcement Report
BioPlex 2200, Anti-CCP Reagent Pack recalled by Bio-Rad Laboratories
Bio-Rad Laboratories is recalling BioPlex 2200, Anti-CCP Reagent Pack, distributed nationwide in the US. The recall was initiated on 21 Feb 2023 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1377-2023
- FDA event ID
- 91854
- Recalling firm
- Bio-Rad Laboratories, Redmond, WA
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 21 Feb 2023
- FDA classified
- 12 Apr 2023
- Reported
- 19 Apr 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- N/A
- Reason category
- Other Reasons
- Device type
- Test Kits & Diagnostics
Timeline
| 21 Feb 2023 | Recall initiated by company | |
| 12 Apr 2023 | Classified by FDA | +50 days |
| 19 Apr 2023 | Published in enforcement report | +7 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positives.
Product as listed by the FDA
BioPlex 2200, Anti-CCP Reagent Pack, REF 665-3250, IVD
Where it was distributed
Worldwide distribution - US Nationwide and the countries of Canada, Czech Republic, Germany, Spain, France, United Kingdom, Israel, Italy, Norway, Sweden.
Questions about this recall
Why was it recalled?
Bio-Rad received four customer complaints from 11/30/2022 to 12/21/2022 on BioPlex 2200 Anti-CCP Kit (Lot 301481) stating that results were discrepant while performing lot-to-lot validation against previous lots. Internal testing at Bio-Rad has demonstrated that Lot No. 301481 exhibits a specificity of 94.5% (95% CI 91.8 96.4) whereas the IFU indicates a specificity of 97.8% (95% CI 96.1 98.8%). The reduction in specificity may lead to an increase in the number of false positives.
Which lots are affected?
Lot # 301481; UDI GTIN: 00847865000857
Where was it sold?
Worldwide distribution - US Nationwide and the countries of Canada, Czech Republic, Germany, Spain, France, United Kingdom, Israel, Italy, Norway, Sweden.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 91854This product is part of a recall event; the main page for the event is BioPlex 2200, Anti-CCP Calibrator Set recalled by Bio-Rad Laboratories.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | BioPlex 2200, Anti-CCP Calibrator Set recalled by Bio-Rad Laboratories | Bio-Rad Laboratories | Other | Nationwide |
More recalls from Bio-Rad Laboratories
All 27| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Platelia Toxo IgM recalled by Bio-Rad Laboratories | Bio-Rad Laboratories | Potency & Assay | Nationwide |
| Device | CLASS II | Bio-Rad, REF: 12005660, QXDx Bcr-abl %IS Kit recalled | Bio-Rad Laboratories | Other | Nationwide |
| Device | CLASS II | BioPlex 2200 REF 665-2050, Apls IgM Pack, Apls IgM Reagent Pack recalled | Bio-Rad Laboratories | Packaging Defects | Nationwide |
| Device | CLASS II | BioPlex 2200, Anti-CCP Calibrator Set recalled by Bio-Rad Laboratories | Bio-Rad Laboratories | Other | Nationwide |
| Device | CLASS II | CMV IgM EIA, in vitro diagnostic recalled by Bio-Rad Laboratories | Bio-Rad Laboratories | Potency & Assay | 14 states |
Other Test Kits & Diagnostics recalls
All 2,661| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | McKesson Consult hCG Urine Cassette recalled by Alere San Diego | Alere San Diego | Potency & Assay | Nationwide |
| Device | CLASS II | Systems/units containing affected recalled | Beckman Coulter Mishima K.K | Device Malfunction | Nationwide |
| Device | CLASS II | Fisher Scientific Sure-Vue Urine hCG recalled by Alere San Diego | Alere San Diego | Potency & Assay | Nationwide |
| Device | CLASS II | Vitek 2 Ast-N461 Test Kit, Gram Negative Susceptibility recalled | Biomerieux | Other | MO |
| Device | CLASS II | DASH Rapid PCR Instrument recalled by Nuclein | Nuclein | Device Malfunction | Nationwide |